Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of FK463 for the Treatment of Invasive Aspergillosis

This study has been completed.
Sponsor:
Information provided by:
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00036166
First received: May 8, 2002
Last updated: April 4, 2011
Last verified: April 2011